Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Flagship blends three biotech startups to form Etcelera

Etiome, Cellarity and Empress Therapeutics are being combined into one new AI-aided drugmaker claiming to possess the ability to better predict the way new medicines will fare in humans.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Thursday 29 October →